Atherectomy Devices Market Size, Share, Opportunities, And Trends By Product Type (Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, Laser Atherectomy Devices, Photo-Ablative Atherectomy Devices, Others), By Application (Peripheral Vascular, Cardiovascular, Neurovascular), By End-User (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Others), And By Geography - Forecasts From 2025 To 2030

Atherectomy Devices Market Size

The atherectomy devices market is estimated to grow from US$1,186.030 million in 2025 to US$1,686.032 million by 2030,  at a CAGR of 7.29%.

An atherectomy device is a type of device that is designed to remove plaque or other types of materials from atherosclerotic vessels. There are various types of atherectomy procedures, which include excisional atherectomy, laser ablation atherectomy, and rotational atherectomy among others.

The rapid advancements in medical technology are among the key factors driving the growth of the global atherectomy device market during the forecast period.

In recent years, this market has experienced significant expansion, largely due to the introduction and development of safer and more efficient devices.

Increasing demand for minimally invasive procedures is also among the major factors pushing the growth of the global atherectomy device market during the forecasted timeline. The global market witnessed a major shift towards minimal and low-invasive surgeries, as they help reduce the recovery time and lowers complication rates. The high cost of equipment and devices is one of the primary challenges to the growth of global atherectomy devices during the forecast period. The development of these devices entails significant expenses in research and contributes to rising manufacturing costs. Furthermore, the device also dilates the arteries of patients, which may lead to increased rates of restenosis, ultimately affecting the long-term effectiveness of the device.

Atherectomy Devices Market Growth Drivers:

• Increasing prevalence of cardiovascular diseases

A major factor propelling the growth of the atherectomy device market is the increasing prevalence of cardiovascular diseases across the globe. With the increasing global cases of cardiovascular diseases, like Peripheral Artery Disease (PAD), and Coronary Artery Diseases (CAD), atherectomy devices help restore healthy blood flow and minimize the symptoms of peripheral artery diseases. The American Heart Association, Inc., in its report, stated that the total cases of peripheral artery disease (PAD) across the globe is estimated at about 200 million. The agency further stated that in the USA, the cases of PAD are estimated at about 12 million. The prevalence of peripheral artery disease in individuals above the age of 70 years is among the highest compared to other age groups, as stated by the agency. Similarly, the Center for Disease Control, of the USA stated that in the USA, the total cases of heart disease in the nation was recorded at 702,880 in 2022, which is about 1 in every 5 people.

• Growing global adult population

The growing adult population in the global market is one of the key factors driving the expansion of the atherectomy devices market during the forecast period. As the number of older individuals increases, so does the prevalence of chronic diseases, including cardiovascular conditions, leading to significant growth in this sector. The global population above the age of 65 years witnessed a major growth during the past few years. The World Bank, in its report, stated that in 2021, the total population above the age of 65 years was recorded at 754.681 million, which increased to 778.122 million in 2022. In 2023, the total population above the age of 65 years across the globe was recorded at 804.475 million.

• Shift of consumer preference towards minimal invasive surgeries.

The shift in consumer preference toward minimally invasive surgeries (MIS) is a significant factor driving the growth of atherectomy devices during the projected period. Atherectomy is a therapeutic procedure that provides a minimally invasive approach to treating vascular conditions. The primary reason for this shift is the lower complication rates associated with minimally invasive surgeries, which play a critical role for patients suffering from various chronic diseases, such as cardiovascular disease and diabetes. Additionally, the atherectomy procedure helps minimize the risk of infections and trauma related to surgical interventions

Atherectomy Devices Market Geographical Outlook:

• North America is forecasted to hold a major share of the atherectomy devices market.

The North American region is expected to witness significant growth in the global atherectomy devices market, during the forecasted timeline. The major factor propelling the growth of atherectomy devices in the North American region, is the increasing cases of cardiovascular diseases, majorly in the USA and Canada. The cases of cardiovascular diseases, in the USA, witnessed a major growth, during the forecasted timeline. Furthermore, the improvement in the healthcare sector in the region is also among the key factors propelling the growth of the market during the estimated timeline. Countries in the region, especially in the USA and Canada, witnessed a significant growth.

Atherectomy Devices Market Products Offered by Key Companies:

• Boston Scientific Corporation is among the global leaders in the biotechnology sector. The company offers a wide range of products and solutions, for professionals and patients. The company offers products for multiple specialties, which include gastroenterology, electrophysiology, pain medicine, neurological surgery, urology, and vascular surgery among others. The products of the company include band ligators, atherectomy systems, catheters, and deep brain stimulation systems among others. In the global atherectomy system market, the company offers Rotational Atherectomy and Rotablator Rotational Atherectomy Systems.
• BD or Becton, Dickinson, and Company is among the global leaders in medical technology, based in America. The company offers a wide range of products and solutions across multiple therapeutic and clinical areas, which includes vascular surgery, biopsy, surgical instruments, urology, cervical cancer screening, and molecular diagnostics among others. In the global atherectomy device market, the company offers a Rotational Excisional Atherectomy System, which features a modified beveled tip, and rotating abrading vortex.
• Abbott Laboratories is an American-based medical device and healthcare market leader. Across the global medical device market, the company offers solutions for multiple therapies, which include anti-infective, cardio-diabetes, GI & Hepato, hormones, pain management, and vaccines among others. The company also offers solutions for nutrition, diabetes care, vascular, diagnostics, and pharmaceuticals among others. In the global atherectomy device market, the company offers the Diamondback 360 Precision device for coronary orbital atherectomy systems.

Atherectomy Devices Market Key Developments:

• In January 2024, AngioDynamics, a global leader in biotechnology and biomedical engineering, announced that the company received US Food and Drug Administration (FDA) approval for its Auryon XL Radical Access Catheter. The solution helps in reducing the access site complication and accelerates patient recovery. The system also helps in expanding treatment access points in atherectomy procedures for Peripheral Arterial Disease (PAD).

Atherectomy Devices Market Scope:

Report Metric	Details
Atherectomy Devices Market Size in 2025	US$1,186.030 million
Atherectomy Devices Market Size in 2030	US$1,686.032 million
Growth Rate	CAGR of 7.29%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Million
Segmentation	Technology Application End-User Geography
Geographical Segmentation	North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in the Atherectomy Devices Market	Boston Scientific Corporation Mitra Industries ITPL Medical Olympus America Duomed
Customization Scope	Free report customization with purchase

 

The Atherectomy Devices Market is analyzed into the following segments:

• By Product Type
  • Directional Atherectomy Devices
  • Rotational Atherectomy Devices
  • Orbital Atherectomy Devices
  • Laser Atherectomy Devices
  • Photo-Ablative Atherectomy Devices
  • Others
• By Application
  • Peripheral Vascular
  • Cardiovascular
  • Neurovascular
• By End-User
  • Hospitals
  • Research Laboratories
  • Ambulatory Surgical Centers
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Isreal
    • Others
  • Asia Pacific Region
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Taiwan
    • Others

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. The Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. ATHERECTOMY DEVICES MARKET BY PRODUCT TYPE 

5.1. Introduction

5.2. Directional Atherectomy Devices

5.3. Rotational Atherectomy Devices

5.4. Orbital Atherectomy Devices

5.5. Laser Atherectomy Devices

5.6. Photo-Ablative Atherectomy Devices

5.7. Others

6. ATHERECTOMY DEVICES MARKET BY APPLICATION

6.1. Introduction

6.2. Peripheral Vascular

6.3. Cardiovascular

6.4. Neurovascular

7. ATHERECTOMY DEVICES MARKET BY END-USER

7.1. Introduction

7.2. Hospitals

7.3. Research Laboratories

7.4. Ambulatory Surgical Centers

7.5. Others

8. ATHERECTOMY DEVICES MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Product Type

8.2.2. By Application

8.2.3. By End-User

8.2.4. By Country

8.2.4.1. United States

8.2.4.2. Canada

8.2.4.3. Mexico

8.3. South America

8.3.1. By Product Type

8.3.2. By Application

8.3.3. By End-User

8.3.4. By Country

8.3.4.1. Brazil

8.3.4.2. Argentina

8.3.4.3. Others

8.4. Europe

8.4.1. By Product Type

8.4.2. By Application

8.4.3. By End-User

8.4.4. By Country

8.4.4.1. Germany

8.4.4.2. France

8.4.4.3. United Kingdom

8.4.4.4. Spain

8.4.4.5. Others

8.5. Middle East and Africa

8.5.1. By Product Type

8.5.2. By Application

8.5.3. By End-User

8.5.4. By Country

8.5.4.1. UAE

8.5.4.2. Saudi Arabia

8.5.4.3. Others

8.6. Asia Pacific

8.6.1. By Product Type

8.6.2. By Application

8.6.3. By End-User

8.6.4. By Country

8.6.4.1. Japan

8.6.4.2. China

8.6.4.3. India

8.6.4.4. South Korea

8.6.4.5. Indonesia

8.6.4.6. Thailand

8.6.4.7. Taiwan

8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Boston Scientific Corporation

10.2. BD (Becton, Dickinson, and Company)

10.3. Abbott

10.4. Koninklijke Philips N.V.

10.5. Medtronic

10.6. AngioDynamics

10.7. Biomerics

10.8. Avinger

10.9. Cardio Flow, Inc.

10.10. InspireMD, Inc

10.11. AMETEK Inc. 

Boston Scientific Corporation

BD (Becton, Dickinson, and Company)

Abbott

Koninklijke Philips N.V.

Medtronic

AngioDynamics

Biomerics

Avinger

Cardio Flow, Inc.

InspireMD, Inc

AMETEK Inc.